central serous chorioretinopathy/nausea

We report the case of a 44-year-old woman with breast cancer who experienced visual loss and altered color vision after two cycles of chemotherapy with 5 fluorouracil, epirubicin, and cyclophosphamide. She was referred to our Ophthalmology department with suspicion of toxic optic neuropathy.

OBJECTIVE To compare the incidence of adverse reactions following rapid versus slow fluorescein injection for fundus angiography. METHODS This randomized controlled trial was performed on 500 patients with retinal vascular disorders. Subjects with central serous retinopathy, age-related macular

OBJECTIVE To report the efficacy and safety of fluorescein angiography after oral administration of fluorescein solution in a large number of patients during a period of 8 years. METHODS A total of 1,787 patients (2,625 eyes) underwent fluorescein angiography after oral administration of sodium